ncartSciences Inc (HSCS) USD0.001

Sell:$3.37Buy:$3.55$0.01 (0.29%)

Prices delayed by at least 15 minutes
Sell:$3.37
Buy:$3.55
Change:$0.01 (0.29%)
Prices delayed by at least 15 minutes
Sell:$3.37
Buy:$3.55
Change:$0.01 (0.29%)
Prices delayed by at least 15 minutes

Company Information

About this company

HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.

Key people

Andrew Simpson
Chairman of the Board, President, Chief Executive Officer
Danielle Watson
Chief Financial Officer, Treasurer
Mark Hilz
Chief Operating Officer, Secretary, Director
Bruce Bent
Independent Director
Brian Szymczak
Independent Director
David R. Wells
Independent Director
Click to see more

Key facts

  • EPIC
    HSCS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US42254E3027
  • Market cap
    $3.74m
  • Employees
    15
  • Shares in issue
    1.08m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.